[Renoprotective effects of matrine on experimental glomerulosclerosis in rats].
OBJECTIVE
Matrine has an anti-fibrosis effect, such as hepatic cirrhosis and derma fibrosis, while its effect on glomerulosclerosis is unknown. The purpose of this study was to analyze the renoprotective effects of matrine on experimental glomerulosclerosis in rats and inquire into its mechanisms.


METHODS
The rats were randomly assigned to following groups: normal control group, model control group, benazepril treatment group, matrine 100 mg/kg treatment group and matrine 50 mg/kg treatment group. The rats of normal control group were subjected to sham operation and were injected with normal saline via the tail vein one week later. The rats of the other groups were uninephrectomized and injected with adriamycin (5 mg/kg) via the tail vein one week later. The dose of benazepril was 6 mg/kg. Both matrine and benazepril were given by gastric perfusion from the first day after the operation. The level of urinary protein was measured at the 2nd, 4th and 6th week after the operation. The serum total protein and albumin, serum creatinine, blood urea nitrogen (BUN) were tested only at the 6th week after operation. Renal pathology changes were evaluated at the 6th week as well. Immunohistochemistry was used to detect the expression of fibronectin (FN), laminin (LN), connective tissue growth factor (CTGF) and transforming growth factor-beta1 (TGF-beta1) in glomeruli.


RESULTS
Matrine and benazepril not only reduced the excretion of urinary protein and the level of serum creatinine and BUN, but also significantly ameliorated glomerular mesangial proliferation and glomerular sclerosis (P < 0.05, respectively). Immunohistochemical staining indicated that there was an increasing FN, LN, CTGF and TGF-beta1 expression in model control group as compared to the three treatment groups (P < 0.05). Matrine 100 mg/kg treatment group and benazepril treatment group showed much more advantages than matrine 50 mg/kg treatment group (P < 0.05), but there was no significant difference between the former two groups (P > 0.05).


CONCLUSIONS
Matrine has a renoprotective effect on experimental glomerulosclerosis in rats, the possible mechanism might relate to the reduction of the TGF-beta1 negative function via CTGF, which will inhibit the activation and proliferation of glomerular intrinsic cells, decrease the secretion of ECM accordingly.
Zhang
Hong-wen
HW
Department of Pediatrics, The First Affiliated Hospital, Lanzhou Medical College, Lanzhou 730000, China.
Jin
Yu
Y
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000517:prevention & control*; D007678:Kidney Glomerulus / Q000187:drug effects; D020011:Protective Agents / Q000494:pharmacology*; D011807:Quinolizines / Q000494:pharmacology*; D051381:Rats; D012076:Renal Agents / Q000494:pharmacology*; D000093842:Matrines
D000470:Alkaloids; D001552:Benzazepines; D020011:Protective Agents; D011807:Quinolizines; D012076:Renal Agents; C044946:benazepril; D000093842:Matrines